This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Pavlou, A. K. & Belsey, M. J. From the analyst's couch: Biopharma licensing and M&A trends. Nature Rev. Drug Discov. 4, 273–274 (2005).
PriceWaterhouseCoopers. High-performing strategic alliances in the pharmaceutical, biotechnology and medical device and diagnostic industries, [online] (1999)
Kogut, B. in Co-operative Strategies in International Business (eds Contractor, F. J. & Lorange, P.) 169–185 (Lexington, Massachusetts, 1988).
Jones, A. & Clifford, L. From the analyst's couch: Drug discovery alliances. Nature Rev. Drug Discov. 4, 807–808 (2005).
DiMasi, J. A. Risks in new drug development: approval success rates for investigational drugs. Clin. Pharmacol. Ther. 69, 297–307 (2001).
Gambardella, A., Orsenigo, L. & Pammolli, F. Global competitiveness in pharmaceuticals: a European perspective, [online] (2001).
CMR International 2005/2006 Pharmaceutical R&D Fact Book. Centre for Medicines Research International Ltd, [online] (2005).
Author information
Authors and Affiliations
Related links
Rights and permissions
About this article
Cite this article
Lou, K., Rond, M. The 'not invented here' myth. Nat Rev Drug Discov 5, 451–452 (2006). https://doi.org/10.1038/nrd2063
Issue Date:
DOI: https://doi.org/10.1038/nrd2063
This article is cited by
-
Minimizing leakage of value from R&D alliances
Nature Reviews Drug Discovery (2007)
-
What's wrong with drug screening today
Nature Chemical Biology (2007)